Brief: Grifols To Build Plant In Spain To Double Its Plasma Fractionation Capacity
July 16 (Reuters) - Grifols SA GRLS.MC: TO BUILD NEW PLANT IN SPAIN TO DOUBLE ITS PLASMA FRACTIONATION CAPACITY IN EUROPE PLANT WILL BEGIN OPERATIONS IN 2030 AND WILL ALLOW COMPANY TO PRODUCE MORE PLASMA-DERIVED MEDICATIONS TO INVEST 160 MILLION EUROS IN PLANT THAT WILL BE LOCATED IN LLIÇÀ DE VALL (BARCELONA) Further company coverage: GRLS.MC (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Grifols SA
See all newsSpanish stocks - Factors to watch on June 24
Brief: Grifols Approves Reduction Of Up To 10% Of Its Share Capital
Brief: Grifols Launches Fibrinogen Concentrate For Acute Bleeding Episodes In The U.S.
Brief: Grifols' Egypt Unit Adds €180 Mln Of Additional Investment In Project
Spanish stocks - Factors to watch on June 12